Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangze Li

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
British Journal of Clinical Pharmacology|February 3, 2022
Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP-ribose) polymerase inhibitor, in subjects with advanced solid cancersYicong Bian, Jian Meng, Sheng Ma, et al.
Environmental Pollution (Barking, Essex : 1987)|January 12, 2025
Emission reduction characteristics of heavy-fuel aircraft piston engine fueled with 100% HEFA sustainable aviation fuelZheng Xu, Yukun Fan, Yinger Zheng, et al.
Frontiers in Pharmacology|April 17, 2023
A mass balance study of [<sup>14</sup>C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humansHua Zhang, Shu Yan, Yan Zhan, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|April 17, 2026
Dissecting the genetic architecture of silique-related traits in rapeseed (Brassica napus L.) through genome-wide association studies and transcriptome analysisCuiping Zhang, Guangze Li, Ruolin Gong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2021
Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [<sup>14</sup>C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-GlucuronosyltransferaseYuandong Zheng, Hua Zhang, Mengling Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2021
Mechanistic Study on the Species Differences in Excretion Pathway of HR011303 in Humans and RatsZitao Guo, Mengling Liu, Jian Meng, et al.
Ecotoxicology and Environmental Safety|April 4, 2025
Ultrafine particles deposition in human respiratory tract: Experimental measurement and modelingLongfei Chen, Muhammad Yousaf, Jingsha Xu, et al.
The Science of the Total Environment|April 14, 2024
A convolutional neural network prediction model for aviation nitrogen oxides emissions throughout all flight phasesLongfei Chen, Qian Zhang, Meiyin Zhu, et al.
Biomolecules|October 19, 2019
Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTAAna Y Estevez, Mallikarjunarao Ganesana, John F Trentini, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 23, 2020
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumorsHuiping Li, Rongrui Liu, Bin Shao, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
British Journal of Clinical Pharmacology|February 3, 2022
Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP-ribose) polymerase inhibitor, in subjects with advanced solid cancersYicong Bian, Jian Meng, Sheng Ma, et al.
Environmental Pollution (Barking, Essex : 1987)|January 12, 2025
Emission reduction characteristics of heavy-fuel aircraft piston engine fueled with 100% HEFA sustainable aviation fuelZheng Xu, Yukun Fan, Yinger Zheng, et al.
Frontiers in Pharmacology|April 17, 2023
A mass balance study of [<sup>14</sup>C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humansHua Zhang, Shu Yan, Yan Zhan, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|April 17, 2026
Dissecting the genetic architecture of silique-related traits in rapeseed (Brassica napus L.) through genome-wide association studies and transcriptome analysisCuiping Zhang, Guangze Li, Ruolin Gong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2021
Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [<sup>14</sup>C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-GlucuronosyltransferaseYuandong Zheng, Hua Zhang, Mengling Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2021
Mechanistic Study on the Species Differences in Excretion Pathway of HR011303 in Humans and RatsZitao Guo, Mengling Liu, Jian Meng, et al.
Ecotoxicology and Environmental Safety|April 4, 2025
Ultrafine particles deposition in human respiratory tract: Experimental measurement and modelingLongfei Chen, Muhammad Yousaf, Jingsha Xu, et al.
The Science of the Total Environment|April 14, 2024
A convolutional neural network prediction model for aviation nitrogen oxides emissions throughout all flight phasesLongfei Chen, Qian Zhang, Meiyin Zhu, et al.
Biomolecules|October 19, 2019
Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTAAna Y Estevez, Mallikarjunarao Ganesana, John F Trentini, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 23, 2020
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumorsHuiping Li, Rongrui Liu, Bin Shao, et al.
Pageof 3